Abstract
Kir2.0 channels play a significant role in setting the resting membrane potential, modulating action potential wave form, and buffering extracellular potassium. One member of this family, Kir2.3, is highly expressed in the heart and brain and is modulated by a variety of factors, including arachidonic acid (AA). Using two-electrode voltage clamp and inside-out patch clamp recordings from Xenopus laevis oocytes expressing Kir2.3 channels, we found that AA selectively activated Kir2.3 channels with an EC50 of 0.59 μM and that this activation required phosphatidyl inositol 4,5-bisphosphate (PIP2). We found that AA activated Kir2.3 by enhancing channel-PIP2 interactions as demonstrated by a shift in PIP2 activation curve. EC50 for channel activation by PIP2 were 36 and 12 μM in the absence and presence of AA, respectively. A single point mutation on the channel C terminus that enhanced basal channel-PIP2 interactions reduced the sensitivity of the channel to AA. Effects of AA are mediated through cytoplasmic sites on the channel by increasing the open probability, mainly due to more frequent bursts of opening in the presence of PIP2. Therefore, enhanced interaction with PIP2 is the molecular mechanism for Kir2.3 channel activation by AA.
Footnotes
-
This work was supported by National Natural Science Foundation of China grant 30730031 and by National Basic Research Program grant 2007CB512100. H.Z. is a beneficiary of the National Science Fund for Distinguished Young Scholars of China grant 30325038. T.M. is supported by Beginning Grant-in-Aid 0765275U from the American Heart Association.
-
ABBREVIATIONS: Kir, inwardly rectifying potassium channel; PKC, protein kinase C; AA, arachidonic acid; PIP2, phosphatidyl inositol 4,5-bisphosphate; MS-222, ethyl 3-aminobenzoate; HK, high-potassium solution; LK, low-potassium solution; LC-PIP2, long-chain (arachidonylstearoyl) PIP2; BSA, bovine serum albumin; diC8PIP2, dioctanoyl-PIP2.
- Received October 30, 2007.
- Accepted January 15, 2008.
- The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|